<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="55" height="12" font="1">May 11, 2011</text>
<text top="341" left="94" width="449" height="12" font="1">See Kirmizis et al. Genes Dev 18:1592; 2004.  A 366-bp fragment from the N terminus and a 318-bp fragment </text>
<text top="353" left="94" width="446" height="12" font="1">from the C terminus of Suz12  were cloned into the Pet15b vector. Protein expression and purification were </text>
<text top="365" left="94" width="429" height="12" font="1">performed using the Bugbuster His-bind Purification Kit. The N- and C-terminal protein fragments were </text>
<text top="377" left="94" width="447" height="12" font="1">combined in equal amounts ;  rabbit immunizations and antibody purifications were performed at Covance.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="81" height="12" font="1">pfarnham@usc.edu</text>
<text top="134" left="83" width="66" height="12" font="1">Peggy Farnham</text>
<text top="215" left="121" width="27" height="12" font="1">SUZ12</text>
<text top="215" left="339" width="60" height="12" font="1">SUZ12 protein</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="55" height="12" font="1">Farnham Lab</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="60" height="12" font="1">not applicable</text>
<text top="300" left="215" width="55" height="12" font="1">Farnham Lab</text>
<text top="521" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="48" height="12" font="2">Protein A/G</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="638" left="103" width="160" height="12" font="2">Kirmizis et al. Genes Dev 18:1592; 2004</text>
<text top="425" left="94" width="444" height="12" font="1">SUZ12 is a component of the PRC2 complex. This complex also contains EZH2, which trimethylates histone </text>
<text top="437" left="94" width="65" height="12" font="1">H3 on lysine 27.</text>
<text top="599" left="238" width="60" height="12" font="1">not applicable</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="420" height="12" font="1">(A) The Suz12 antibody detects only one major band on a western blot. SW480 cells were transfected </text>
<text top="92" left="125" width="401" height="12" font="1">with an HA-Suz12 or a control (HA-empty) construct and subjected to immunoblot analysis. Two </text>
<text top="104" left="125" width="421" height="12" font="1">separate blots were prepared and probed with either an HA antibody (left panel) or a Suz12 antibody </text>
<text top="116" left="125" width="420" height="12" font="1">(right panel). The HA antibody recognizes only the HA-Suz12 protein and the Suz12 antibody detects </text>
<text top="128" left="125" width="396" height="12" font="1">both the HA-Suz12 and endogenous Suz12 proteins. See Kirmizis et al. Genes Dev. 2004 Jul 1;18</text>
<text top="140" left="125" width="65" height="12" font="1">(13):1592-605.   </text>
<text top="152" left="125" width="422" height="12" font="1"> (B) Knockdown of Suz12 using siRNAs demonstrates that the single band detected by Western blot is </text>
<text top="164" left="125" width="408" height="12" font="1">SUZ12.  Western blot analysis of whole cell extracts prepared from the indicated cells after a 6-day </text>
<text top="176" left="125" width="394" height="12" font="1">transfection with SUZ12 siRNA, GFP siRNA, or no siRNA (Mock). The levels of actin are shown to </text>
<text top="188" left="125" width="434" height="12" font="1">demonstrate approximately equal loading of protein samples. As expected, since SUZ12 is a component </text>
<text top="200" left="125" width="421" height="12" font="1">of PRC2, the H3K27me3 signal was also greatly reduced.  However, H3K9me3 levels were unchanged. </text>
<text top="212" left="125" width="230" height="12" font="1">See Squazzo et al. Genome Res. 2006 Jul;16(7):890-900. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="117" left="130" width="421" height="12" font="1">SUZ12 is a component of the PRC2 complex, which also contains the histone methyltransferase EZH2 </text>
<text top="129" left="130" width="420" height="12" font="1">that can methylate histone H3 on lysine 27.  ChIP-seq analysis was performed in Ntera2 cells using an </text>
<text top="141" left="130" width="404" height="12" font="1">antibody to SUZ12 and to H3K27me3; two replicates of each were performed.  The overlap of the </text>
<text top="153" left="130" width="422" height="12" font="1">SUZ12 replicates was 99% and the overlap of the H3K27me3 replicates was 98%.  The peak sets of the </text>
<text top="165" left="130" width="421" height="12" font="1">merged SUZ12 and the merged H3K27me3 datasets were then overlapped.  80% (8419) of the SUZ12 </text>
<text top="177" left="130" width="392" height="12" font="1">called peaks were found within the H3K27me3 called peaks.  [It should be noted that a smaller </text>
<text top="189" left="130" width="424" height="12" font="1">percentage of the H3K27me3 sites will overlap with SUZ12 sites because the H3K27me3 mark spreads </text>
<text top="201" left="130" width="186" height="12" font="1">over longer distances than the SUZ12 mark.] </text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
